OK Biotech Co., Ltd. (4155.TW)
TWD 20.9
(-0.71%)
TWD 20.9
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.93 Million | 240.52 Million | 21.89 Million | 147.7 Million | 45.17 Million | 128.75 Million |
| Net Income | 8.02 Million | 175.59 Million | 46.14 Million | 151.65 Million | 143.37 Million | 201.59 Million |
| Depreciation & Amortization | 75.54 Million | 67.88 Million | 55.88 Million | 50.07 Million | 41.55 Million | 30.28 Million |
| Deferred income taxes | -32.13 Million | - | -19.01 Million | -13.13 Million | -44 Million | -6.06 Million |
| Stock-based compensation | 3.26 Million | - | 3.39 Million | 3.73 Million | 5.4 Million | 6.23 Million |
| Change in working capital | -46.18 Million | -56.75 Million | -66.68 Million | -43.34 Million | -104.83 Million | -98.52 Million |
| Other non-cash items | -5.57 Million | 53.8 Million | 2.18 Million | -1.28 Million | 3.67 Million | -4.77 Million |
| Investing Cash Flow | -358.38 Million | -294.23 Million | -174.46 Million | -126.96 Million | -85.49 Million | -62.18 Million |
| Investments in PPE | -437.07 Million | -294.24 Million | -86.46 Million | -79.79 Million | -77.95 Million | -28.36 Million |
| Acquisitions | 12.1 Million | 5.09 Million | 3.1 Million | -30 Million | 1.8 Million | -707 Thousand |
| Investment purchases | -12.1 Million | -5 Million | -91.02 Million | -19.73 Million | -16 Million | -5.55 Million |
| Sales/Maturities of investments | 66.6 Million | -5.09 Million | -3.1 Million | - | 119 Thousand | 816 Thousand |
| Other Investing Activities | 12.09 Million | 5.01 Million | 3.02 Million | 2.56 Million | 6.53 Million | -28.37 Million |
| Financing Cash Flow | 82.06 Million | 50.26 Million | 185.69 Million | 215.81 Million | 185.07 Million | -337.9 Million |
| Debt repayment | -12.59 Million | -1.89 Billion | -1.27 Billion | -2.63 Billion | -687.82 Million | -1.27 Billion |
| Dividends payments | -144.64 Million | -94.93 Million | -131.85 Million | -112.14 Million | -166.38 Million | -111.34 Million |
| Common Stock Repurchased | - | - | - | 2.55 Billion | -5.73 Million | -39.59 Million |
| Common Stock Issuance | 270 Million | - | 27.24 Million | 403 Million | 5.73 Million | 1.13 Billion |
| Other Financing Activities | 239.3 Million | 2.03 Billion | 1.56 Billion | 5.29 Million | 1.03 Billion | -39.59 Million |
| Accounts receivables | -78.91 Million | -71.86 Million | -86.72 Million | -29 Million | -29.38 Million | -53.15 Million |
| Accounts payables | -45.5 Million | 6.09 Million | 32.85 Million | -11.42 Million | 20.49 Million | 47.23 Million |
| Inventory | 28.9 Million | -47.31 Million | -26.56 Million | 8.8 Million | -87.99 Million | -70.68 Million |
| Other working capital | 49.33 Million | 56.32 Million | 13.75 Million | -11.72 Million | -7.94 Million | -27.84 Million |
| Cash at beginning of period | 596.41 Million | 599.85 Million | 566.72 Million | 332.31 Million | 184.42 Million | 455.73 Million |
| Cash at end of period | 323.03 Million | 596.41 Million | 599.85 Million | 566.72 Million | 332.31 Million | 184.42 Million |
| Capital Expenditure | -437.07 Million | -294.24 Million | -86.46 Million | -79.79 Million | -77.95 Million | -28.36 Million |
| Effect of forex changes on cash | - | - | - | -2.14 Million | 3.13 Million | 26 Thousand |
| Net cash flow / Change in cash | -273.38 Million | -3.43 Million | 33.13 Million | 234.41 Million | 147.88 Million | -271.31 Million |
| Free Cash Flow | -434.14 Million | -53.71 Million | -64.56 Million | 67.91 Million | -32.77 Million | 100.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 42.26 Million | 47.7 Million | -37.23 Million | 8.02 Million | -272 Thousand | 23.19 Million |
| Depreciation & Amortization | 16.75 Million | 18.83 Million | 17.99 Million | 75.54 Million | 18.99 Million | 19.46 Million |
| Deferred income taxes | - | - | -3.26 Million | -32.13 Million | - | - |
| Stock-based compensation | 4.89 Million | 4.89 Million | 3.26 Million | 3.26 Million | - | - |
| Change in working capital | 68.52 Million | -90.16 Million | 58.78 Million | -46.18 Million | 1.9 Million | -18.29 Million |
| Other non-cash items | 30.4 Million | -1.65 Million | -4.2 Million | -5.57 Million | -7.06 Million | -28.59 Million |
| Investing Cash Flow | -175.51 Million | -33.19 Million | -60.31 Million | -358.38 Million | -4.42 Million | 25.86 Million |
| Investments in PPE | -60.66 Million | -53.87 Million | -82.96 Million | -437.07 Million | -13.08 Million | -307.24 Million |
| Acquisitions | 1.5 Million | - | 1.05 Million | 12.1 Million | 8.73 Million | 2.32 Million |
| Investment purchases | -146.34 Million | - | -1.05 Million | -12.1 Million | - | -47.32 Million |
| Sales/Maturities of investments | 30 Million | - | 21.6 Million | 66.6 Million | - | 45 Million |
| Other Investing Activities | -114.94 Million | 20.67 Million | 1.05 Million | 12.09 Million | -76 Thousand | 333.11 Million |
| Financing Cash Flow | 158.66 Million | -43.44 Million | -159.61 Million | 82.06 Million | 198.48 Million | -13.38 Million |
| Debt repayment | -159.7 Million | -42.42 Million | -2.6 Million | -12.59 Million | -3.33 Million | -3.31 Million |
| Dividends payments | - | - | -144.64 Million | -144.64 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 38.09 Million | 270 Million | 231.9 Million | - |
| Other Financing Activities | -1.03 Million | -40.03 Million | -12.36 Million | 239.3 Million | 201.82 Million | -10.07 Million |
| Accounts receivables | 42.25 Million | -123.28 Million | 30.75 Million | -78.91 Million | -76.83 Million | -11.94 Million |
| Accounts payables | 75.44 Million | 27.23 Million | 9.88 Million | -45.5 Million | 56.83 Million | -6.98 Million |
| Inventory | -85.72 Million | -8.21 Million | -8.78 Million | 28.9 Million | -18.93 Million | 40.28 Million |
| Other working capital | 36.55 Million | 12.81 Million | 26.93 Million | 49.33 Million | 40.83 Million | -39.64 Million |
| Cash at beginning of period | 221.06 Million | 323.03 Million | 507.85 Million | 596.41 Million | 300.06 Million | 291.76 Million |
| Cash at end of period | 360.62 Million | 221.06 Million | 323.03 Million | 323.03 Million | 507.85 Million | 300.06 Million |
| Capital Expenditure | -60.66 Million | -53.87 Million | -82.96 Million | -437.07 Million | -13.08 Million | -307.24 Million |
| Effect of forex changes on cash | - | - | -232 Thousand | - | 170 Thousand | 62 Thousand |
| Net cash flow / Change in cash | 139.56 Million | -101.96 Million | -184.82 Million | -273.38 Million | 207.79 Million | 8.29 Million |
| Free Cash Flow | 95.74 Million | -79.19 Million | -47.62 Million | -434.14 Million | 475 Thousand | -311.49 Million |
ALEO2
0078
603298
5313
1MO
600038